Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HAI Life Science AB
AB
Bankrupt
Org 5591577795
Research and experimental development on biotechnology · NACE 7211
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2020
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2020
—
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
—
—
EBITDA
SEK 0
—
Net profit
—
—
Total assets
—
—
Equity
—
—
Employees
0
—
Company information
Legal name
HAI Life Science AB
Org number
5591577795
Legal form
Aktiebolag
NACE code
7211 · Research and experimental development on biotechnology
Founded
3 maj 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Verksamhet inom biologisk och kemisk forskning, utveckling och rådgivning.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on biotechnology
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
Income statement
SEK thousands
Item
2018
2019
2020
Revenue
—
—
—
Staff expenses
—
—
—
EBITDA
0
0
0
Depreciation & amort.
—
—
—
EBIT
0
0
0
Net financials
—
—
—
Profit before tax
0
0
0
Tax
—
—
—
Net profit
—
—
—
Balance sheet
SEK thousands
Item
2018
2019
2020
Total assets
—
—
—
Equity
—
—
—
Long-term debt
—
—
—
Short-term debt
—
—
—
Total debt
—
—
—
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2018
2020
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2018
2020
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2018
2020
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2018
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2018
2020
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2018
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-05-01 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JR
Jessica Ronak Madani
Liquidator
Liquidator
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (3)
MH
Martin Hällbrink
Deputy Board Member
2022 – 2022
MM
Mattias Martin Hällbrink
Board of Directors
2022 – 2022
ME
Maria Elisabeth Lindgren
Chairman
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of HAI Life Science AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jessica Ronak Madani
Liquidator
0 companies
Martin Hällbrink
Deputy Board Member
0 companies
Mattias Martin Hällbrink
Board of Directors
0 companies
Maria Elisabeth Lindgren
Chairman
0 companies